MedPath

The Effect of tES on a Cognitive Training

Not Applicable
Completed
Conditions
Memory Impairment
Registration Number
NCT03475446
Lead Sponsor
University of Bern
Brief Summary

The aim of this study is to investigate the effect of a transcranial electrical stimulation (tES) on a cognitive training in healthy elderly and memory impaired participants. In order to assess these effects different memory and attention tasks will be performed before and after the training as well as after 6 and 12 months.

Detailed Description

As other studies have shown, transcranial direct current stimulation (tDCS) can improve the outcome of memory tasks in Alzheimer's disease (AD), mild cognitive impairment (MCI) and healthy older adults. Only few studies have investigated the effect of the combination of tDCS and a simultaneous cognitive training and to the investigators' knowledge there is no comparison of tDCS and transcranial alternating current (tACS) effects during a cognitive training or for different populations. With results from this study existing trainings can be optimised. In total 180 participants are planned to be included in this study. This number is based on a g\*Power estimation. According to this estimation the study has to include 153 participants. Regarding similar studies the investigators assume a dropout rate of 15% resulting in a total of 180 participants (60 AD patients, 60 MCI patients and 60 healthy older adults) This number should make it possible to find the expected mild effects reported in literature.

A mixed-effects ANOVA model with the between-subjects factor stimulation (tDCS, tACS, sham) and the within-subjects factor time will be computed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Able to give their consent to participate in the study
  • Native or fluent German speaker
  • Normal or corrected to normal vision and hearing
  • Ability to visit the study location for 14 appointments
Exclusion Criteria
  • Acute neurological (other than memory impairment) or psychiatric disorders
  • Seizures
  • Magnetisable implants
  • High dose of psychotropic drugs
  • Drug or alcohol abuse
  • Participation in another study with investigational drug
  • tES in the 2 months preceding or during the present study
  • Severe head injuries
  • Skin disease
  • Caffeine 3 hours prior to training

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
MemoryFollow-up 2 (12 months after end of training)

The primary outcome is the change in memory performance.Therefore, changes in the MMS/MoCA score (scores: 0-30, higher scores indicate better functioning of global memory and cognition) and a composite memory score will be assessed. The composite memory score is calculated with the scores of the episodic, prospective and working memory tests.

Secondary Outcome Measures
NameTimeMethod
MoodFollow-up 2 (12 months after end of training)

Changes in the subjective measure mood, assessed with questionnaire.

QOLFollow-up 2 (12 months after end of training)

Changes in the subjective measure quality of life, assessed with questionnaire.

AODLFollow-up 2 (12 months after end of training)

Changes in the subjective measure activities of daily living, assessed with questionnaire.

Trial Locations

Locations (1)

Klinik für Alterspsychiatrie und Psychotherapie UPD Bern

🇨🇭

Bern, Switzerland

Klinik für Alterspsychiatrie und Psychotherapie UPD Bern
🇨🇭Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath